National Eye Institute
CompanyUnited StatesFounded 1968
National Eye Institute develops 2 assets, the furthest in phase 3 (NT-501 in macular telangiectasia type 2). Mostly cell therapy; based in the United States, founded in 1968.
- 2
- Assets
- Furthest stage
- Phase 3
- 66
- Grants
- 66
- Trials
- 53
- Signals
Pipeline
2Encapsulated engineered cells release ciliary neurotrophic factor to support retinal photoreceptor survival.
Phase 3, Cell therapy, macular telangiectasia type 2, retinitis pigmentosa (Phase 2)
iPSC-derived RPE/PLGA transplantation
Replaces damaged retinal pigment epithelium with autologous induced pluripotent stem cell-derived cells on a biodegradable scaffold.
Phase 1, Cell therapy, dry age-related macular degeneration, geographic atrophy
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials134
- People11
- Signals20
- Similar companies6
Papers
arXiv, Nov 13, 2026
Eye-photo model maps individual patterns of death risk
Nature biomedical engineering, Nov 2, 2026
Automated Segmentation of Retinal Pigment Epithelium Layers in High-Resolution OCT
Ophthalmology science, Oct 15, 2026
Donor light-sensing cells may connect in a non-human primate
Stem cell reports, Oct 14, 2026
Eye photos help estimate heart and artery disease risk
Ophthalmology science, Oct 12, 2026
Engineered cardiac transcription factor restores vision and reduces frailty in aging mice
bioRxiv, Oct 2, 2026
Annual review of vision science, Sep 15, 2026
Older mice had tighter DNA packing in light-sensing cells
Research square, Sep 3, 2026
Cell powerhouses differed by eye deposit type in aged macaques
Redox biology, Aug 25, 2026
Investigative ophthalmology & visual science, Aug 19, 2026
An Integrated Multi-omics Single Cell Atlas of the Human RPE and Choroid
bioRxiv : the preprint server for biology, Aug 1, 2026
Ophthalmology. Retina, Jul 30, 2026
A protein helps eye cells resist oxidative damage in mice
The Journal of clinical investigation, Jul 7, 2026
Nature cardiovascular research, Jun 17, 2026
Alzheimer's & dementia (Amsterdam, Netherlands), Jun 8, 2026
Adaptive immune crosstalk and complement dysregulation in the aging retina
Tzu chi medical journal, May 14, 2026
bioRxiv : the preprint server for biology, May 13, 2026
Hopx(+) optic nerve head-astrocytes counter neuronal stress and glaucoma damage
Proceedings of the National Academy of Sciences of the United States of America, Apr 27, 2026
Reference Standard for Validation of Age-Related Macular Degeneration Screening Algorithms
Ophthalmology, Apr 19, 2026
What Should Patients With Age-Related Macular Degeneration Eat?
American journal of ophthalmology, Apr 17, 2026